Clinical Trial: Mechanism by Which Gancao Xiexin Decoction Inhibits Gastric Cancer Cell Proliferation via Arresting G1/S Phase Through the hnRNPA0/p27Kip1 Axis (China)

Posted On: 2026-08-10

China, Aug. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Mechanism by Which Gancao Xiexin Decoction Inhibits Gastric Cancer Cell Proliferation via Arresting G1/S Phase Through the hnRNPA0/p27Kip1 Axis'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129762

Registration Time: 2026/08/10

Type: Observational study

Primary Sponsor: China-Japan Friendship Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=330646

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

Clinical Trial: Mechanism by Which Gancao Xiexin Decoction Inhibits Gastric Cancer Cell Proliferation via Arresting G1/S Phase Through the hnRNPA0/p27Kip1 Axis (China)